Progress and promise towards safe induced pluripotent stem cells for therapy

Ali Seifinejad, Mohammadsharif Tabebordbar, Hossein Baharvand, Laurie A. Boyer, Ghasem Hosseini Salekdeh

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.

LanguageEnglish
Pages297-306
Number of pages10
JournalStem Cell Reviews and Reports
Volume6
Issue number2
DOIs
Publication statusPublished - 1 Jun 2010
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Cell- and Tissue-Based Therapy
Virus Integration
Stem Cell Research
Stem Cell Transplantation
Toxicology
Biomedical Research
Pharmaceutical Preparations

Keywords

  • Cell therapy
  • Embryonic stem cells
  • Induced pluripotent stem cells
  • iPSCs
  • Regenerative medicine

Cite this

Seifinejad, Ali ; Tabebordbar, Mohammadsharif ; Baharvand, Hossein ; Boyer, Laurie A. ; Salekdeh, Ghasem Hosseini. / Progress and promise towards safe induced pluripotent stem cells for therapy. In: Stem Cell Reviews and Reports. 2010 ; Vol. 6, No. 2. pp. 297-306.
@article{acd1aa872cdb4d4bb357ee598fd2e2a5,
title = "Progress and promise towards safe induced pluripotent stem cells for therapy",
abstract = "The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.",
keywords = "Cell therapy, Embryonic stem cells, Induced pluripotent stem cells, iPSCs, Regenerative medicine",
author = "Ali Seifinejad and Mohammadsharif Tabebordbar and Hossein Baharvand and Boyer, {Laurie A.} and Salekdeh, {Ghasem Hosseini}",
year = "2010",
month = "6",
day = "1",
doi = "10.1007/s12015-010-9121-x",
language = "English",
volume = "6",
pages = "297--306",
journal = "Stem Cell Reviews and Reports",
issn = "1550-8943",
publisher = "Humana Press",
number = "2",

}

Progress and promise towards safe induced pluripotent stem cells for therapy. / Seifinejad, Ali; Tabebordbar, Mohammadsharif; Baharvand, Hossein; Boyer, Laurie A.; Salekdeh, Ghasem Hosseini.

In: Stem Cell Reviews and Reports, Vol. 6, No. 2, 01.06.2010, p. 297-306.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Progress and promise towards safe induced pluripotent stem cells for therapy

AU - Seifinejad, Ali

AU - Tabebordbar, Mohammadsharif

AU - Baharvand, Hossein

AU - Boyer, Laurie A.

AU - Salekdeh, Ghasem Hosseini

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.

AB - The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.

KW - Cell therapy

KW - Embryonic stem cells

KW - Induced pluripotent stem cells

KW - iPSCs

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=77953914634&partnerID=8YFLogxK

U2 - 10.1007/s12015-010-9121-x

DO - 10.1007/s12015-010-9121-x

M3 - Review article

VL - 6

SP - 297

EP - 306

JO - Stem Cell Reviews and Reports

T2 - Stem Cell Reviews and Reports

JF - Stem Cell Reviews and Reports

SN - 1550-8943

IS - 2

ER -